SGLT2 is a member of the sodium-glucose cotransporter family which are sodium-dependent glucose transport proteins. SGLT2 is the major cotransporter involved in glucose reabsorption in the kidney.The growing global type-2 diabetes population promotes the growth of SGLT2 drugs.

The global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors include Eli Lilly, Janssen Pharmaceuticals, Astellas, Boehringer Ingelheim, AstraZeneca, Bristol Myers Squibb and Kotobuki Pharmaceutical, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:

This report presents an overview of global market for Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Report

Report Metric	Details
Report Name	Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market
Segment by Type	Invokana (Canagliflozin) Jardiance (Empagliflozin) Farxiga/Forxiga (Dapagliflozin) Suglat (Ipragliflozin)
Segment by Application	Hospital Medical Research Institute Other
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Astellas, Boehringer Ingelheim, AstraZeneca, Bristol Myers Squibb, Kotobuki Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market report?

Ans: The main players in the Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market are Astellas, Boehringer Ingelheim, AstraZeneca, Bristol Myers Squibb, Kotobuki Pharmaceutical

What are the Application segmentation covered in the Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market report?

Ans: The Applications covered in the Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market report are Hospital, Medical Research Institute, Other

What are the Type segmentation covered in the Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market report?

Ans: The Types covered in the Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market report are Invokana (Canagliflozin), Jardiance (Empagliflozin), Farxiga/Forxiga (Dapagliflozin), Suglat (Ipragliflozin)

1 Study Coverage

1.1 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction

1.2 Market by Type

1.2.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Invokana (Canagliflozin)

1.2.3 Jardiance (Empagliflozin)

1.2.4 Farxiga/Forxiga (Dapagliflozin)

1.2.5 Suglat (Ipragliflozin)

1.3 Market by Application

1.3.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Medical Research Institute

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Estimates and Forecasts 2019-2030

2.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region

2.2.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2019-2024)

2.2.3 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2025-2030)

2.2.4 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2019-2030)

2.3 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Estimates and Forecasts 2019-2030

2.4 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region

2.4.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2019-2024)

2.4.3 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2025-2030)

2.4.4 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturers

3.1.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturers (2019-2024)

3.1.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors in 2023

3.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturers

3.2.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturers (2019-2024)

3.2.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue in 2023

3.3 Global Key Players of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors, Product Offered and Application

3.8 Global Key Manufacturers of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type

4.1.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Historical Sales by Type (2019-2024)

4.1.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecasted Sales by Type (2025-2030)

4.1.3 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2019-2030)

4.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type

4.2.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Historical Revenue by Type (2019-2024)

4.2.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecasted Revenue by Type (2025-2030)

4.2.3 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2019-2030)

4.3 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Type

4.3.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Type (2019-2024)

4.3.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application

5.1.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Historical Sales by Application (2019-2024)

5.1.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecasted Sales by Application (2025-2030)

5.1.3 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2019-2030)

5.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application

5.2.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Historical Revenue by Application (2019-2024)

5.2.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecasted Revenue by Application (2025-2030)

5.2.3 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2019-2030)

5.3 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Application

5.3.1 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Application (2019-2024)

5.3.2 Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Type

6.1.1 US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2019-2030)

6.1.2 US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2019-2030)

6.2 US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Application

6.2.1 US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2019-2030)

6.2.2 US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2019-2030)

6.3 US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Country

6.3.1 US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2019-2030)

6.3.3 US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Type

7.1.1 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2019-2030)

7.1.2 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2019-2030)

7.2 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Application

7.2.1 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2019-2030)

7.2.2 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2019-2030)

7.3 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Country

7.3.1 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2019-2030)

7.3.3 Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size

8.1.1 China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (2019-2030)

8.1.2 China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030)

8.2 China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Application

8.2.1 China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2019-2030)

8.2.2 China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Type

9.1.1 Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2019-2030)

9.1.2 Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2019-2030)

9.2 Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Application

9.2.1 Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2019-2030)

9.2.2 Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2019-2030)

9.3 Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region

9.3.1 Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2019-2030)

9.3.3 Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Type

10.1.1 Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Application

10.2.1 Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country

10.3.1 Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Eli Lilly

11.1.1 Eli Lilly Company Information

11.1.2 Eli Lilly Overview

11.1.3 Eli Lilly Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Eli Lilly Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Eli Lilly Recent Developments

11.2 Janssen Pharmaceuticals

11.2.1 Janssen Pharmaceuticals Company Information

11.2.2 Janssen Pharmaceuticals Overview

11.2.3 Janssen Pharmaceuticals Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Janssen Pharmaceuticals Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Janssen Pharmaceuticals Recent Developments

11.3 Astellas

11.3.1 Astellas Company Information

11.3.2 Astellas Overview

11.3.3 Astellas Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Astellas Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Astellas Recent Developments

11.4 Boehringer Ingelheim

11.4.1 Boehringer Ingelheim Company Information

11.4.2 Boehringer Ingelheim Overview

11.4.3 Boehringer Ingelheim Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Boehringer Ingelheim Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Boehringer Ingelheim Recent Developments

11.5 AstraZeneca

11.5.1 AstraZeneca Company Information

11.5.2 AstraZeneca Overview

11.5.3 AstraZeneca Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 AstraZeneca Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 AstraZeneca Recent Developments

11.6 Bristol Myers Squibb

11.6.1 Bristol Myers Squibb Company Information

11.6.2 Bristol Myers Squibb Overview

11.6.3 Bristol Myers Squibb Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Bristol Myers Squibb Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Bristol Myers Squibb Recent Developments

11.7 Kotobuki Pharmaceutical

11.7.1 Kotobuki Pharmaceutical Company Information

11.7.2 Kotobuki Pharmaceutical Overview

11.7.3 Kotobuki Pharmaceutical Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Kotobuki Pharmaceutical Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Kotobuki Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Chain Analysis

12.2 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Mode & Process

12.4 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Marketing

12.4.1 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Channels

12.4.2 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors

12.5 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Customers

13 Market Dynamics

13.1 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Trends

13.2 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Drivers

13.3 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Challenges

13.4 Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Restraints

14 Key Findings in The Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Eli Lilly

Janssen Pharmaceuticals

Kotobuki Pharmaceutical

List of Tables

Table 1. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Invokana (Canagliflozin)

Table 3. Major Manufacturers of Jardiance (Empagliflozin)

Table 4. Major Manufacturers of Farxiga/Forxiga (Dapagliflozin)

Table 5. Major Manufacturers of Suglat (Ipragliflozin)

Table 6. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2019-2024)

Table 11. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2025-2030)

Table 12. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2019-2024) & (K Units)

Table 14. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2025-2030) & (K Units)

Table 15. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2019-2024)

Table 16. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2025-2030)

Table 17. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturers (2019-2024) & (K Units)

Table 18. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Manufacturers (2019-2024)

Table 19. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Manufacturers (2019-2024)

Table 21. Global Key Players of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024

Table 22. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Manufacturers 2019-2024 (USD/Unit)

Table 23. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors as of 2023)

Table 25. Global Key Manufacturers of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors, Product Offered and Application

Table 27. Global Key Manufacturers of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2019-2024) & (K Units)

Table 30. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2025-2030) & (K Units)

Table 31. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Type (2019-2024)

Table 32. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Type (2025-2030)

Table 33. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Type (2019-2024)

Table 36. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Type (2025-2030)

Table 37. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Type (2019-2024) & (USD/Unit)

Table 38. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Forecast by Type (2025-2030) & (USD/Unit)

Table 39. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2019-2024) & (K Units)

Table 40. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2025-2030) & (K Units)

Table 41. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Application (2019-2024)

Table 42. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Application (2025-2030)

Table 43. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Application (2019-2024)

Table 46. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Application (2025-2030)

Table 47. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Application (2019-2024) & (USD/Unit)

Table 48. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Forecast by Application (2025-2030) & (USD/Unit)

Table 49. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2019-2024) & (K Units)

Table 50. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2025-2030) & (K Units)

Table 51. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2019-2024) & (K Units)

Table 54. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2025-2030) & (K Units)

Table 55. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2019-2024) & (K Units)

Table 61. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2025-2030) & (K Units)

Table 62. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2019-2024) & (K Units)

Table 63. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2025-2030) & (K Units)

Table 64. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2019-2024) & (K Units)

Table 67. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2025-2030) & (K Units)

Table 68. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2019-2024) & (K Units)

Table 74. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2025-2030) & (K Units)

Table 75. China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2019-2024) & (K Units)

Table 76. China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2025-2030) & (K Units)

Table 77. China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2019-2024) & (US$ Million)

Table 78. China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2025-2030) & (US$ Million)

Table 79. China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2019-2024) & (K Units)

Table 80. China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2025-2030) & (K Units)

Table 81. China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2019-2024) & (US$ Million)

Table 82. China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2019-2024) & (K Units)

Table 84. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2025-2030) & (K Units)

Table 85. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2019-2024) & (K Units)

Table 88. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2025-2030) & (K Units)

Table 89. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2019-2024) & (K Units)

Table 95. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2019-2024) & (K Units)

Table 97. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2025-2030) & (K Units)

Table 98. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2019-2024) & (K Units)

Table 101. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2025-2030) & (K Units)

Table 102. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2019-2024) & (K Units)

Table 108. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2025-2030) & (K Units)

Table 109. Eli Lilly Company Information

Table 110. Eli Lilly Description and Major Businesses

Table 111. Eli Lilly Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 112. Eli Lilly Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Eli Lilly Recent Developments

Table 114. Janssen Pharmaceuticals Company Information

Table 115. Janssen Pharmaceuticals Description and Major Businesses

Table 116. Janssen Pharmaceuticals Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 117. Janssen Pharmaceuticals Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Janssen Pharmaceuticals Recent Developments

Table 119. Astellas Company Information

Table 120. Astellas Description and Major Businesses

Table 121. Astellas Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 122. Astellas Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Astellas Recent Developments

Table 124. Boehringer Ingelheim Company Information

Table 125. Boehringer Ingelheim Description and Major Businesses

Table 126. Boehringer Ingelheim Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 127. Boehringer Ingelheim Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. Boehringer Ingelheim Recent Developments

Table 129. AstraZeneca Company Information

Table 130. AstraZeneca Description and Major Businesses

Table 131. AstraZeneca Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 132. AstraZeneca Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. AstraZeneca Recent Developments

Table 134. Bristol Myers Squibb Company Information

Table 135. Bristol Myers Squibb Description and Major Businesses

Table 136. Bristol Myers Squibb Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 137. Bristol Myers Squibb Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. Bristol Myers Squibb Recent Developments

Table 139. Kotobuki Pharmaceutical Company Information

Table 140. Kotobuki Pharmaceutical Description and Major Businesses

Table 141. Kotobuki Pharmaceutical Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 142. Kotobuki Pharmaceutical Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications

Table 143. Kotobuki Pharmaceutical Recent Developments

Table 144. Key Raw Materials Lists

Table 145. Raw Materials Key Suppliers Lists

Table 146. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors List

Table 147. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Customers List

Table 148. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Trends

Table 149. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Drivers

Table 150. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Challenges

Table 151. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Restraints

Table 152. Research Programs/Design for This Report

Table 153. Key Data Information from Secondary Sources

Table 154. Key Data Information from Primary Sources

List of Figures

Figure 1. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Picture

Figure 2. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2023 & 2030

Figure 4. Invokana (Canagliflozin) Product Picture

Figure 5. Jardiance (Empagliflozin) Product Picture

Figure 6. Farxiga/Forxiga (Dapagliflozin) Product Picture

Figure 7. Suglat (Ipragliflozin) Product Picture

Figure 8. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2023 & 2030

Figure 10. Hospital

Figure 11. Medical Research Institute

Figure 12. Other

Figure 13. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Report Years Considered

Figure 14. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2019-2030 (US$ Million)

Figure 16. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 17. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2019-2030)

Figure 18. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2019-2030 ((K Units)

Figure 19. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2019-2030)

Figure 20. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales YoY (2019-2030) & (K Units)

Figure 21. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue YoY (2019-2030) & (US$ Million)

Figure 22. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales YoY (2019-2030) & (K Units)

Figure 23. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue YoY (2019-2030) & (US$ Million)

Figure 24. China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales YoY (2019-2030) & (K Units)

Figure 25. China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Asia (excluding China) Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales YoY (2019-2030) & (K Units)

Figure 27. Asia (excluding China) Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales YoY (2019-2030) & (K Units)

Figure 29. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue YoY (2019-2030) & (US$ Million)

Figure 30. The Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 31. The Top 5 and 10 Largest Manufacturers of Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors in the World: Market Share by Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue in 2023

Figure 32. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 33. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2019-2030)

Figure 34. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2019-2030)

Figure 35. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2019-2030)

Figure 36. Global Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2019-2030)

Figure 37. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2019-2030)

Figure 38. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2019-2030)

Figure 39. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2019-2030)

Figure 40. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2019-2030)

Figure 41. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Country (2019-2030)

Figure 42. US & Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Country (2019-2030)

Figure 43. U.S. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 44. Canada Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 45. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2019-2030)

Figure 46. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2019-2030)

Figure 47. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2019-2030)

Figure 48. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2019-2030)

Figure 49. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Country (2019-2030)

Figure 50. Europe Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Country (2019-2030)

Figure 51. Germany Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 52. France Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 53. U.K. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 54. Italy Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 55. Russia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 56. China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2019-2030)

Figure 57. China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2019-2030)

Figure 58. China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2019-2030)

Figure 59. China Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2019-2030)

Figure 60. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2019-2030)

Figure 61. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2019-2030)

Figure 62. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2019-2030)

Figure 63. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2019-2030)

Figure 64. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Region (2019-2030)

Figure 65. Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Region (2019-2030)

Figure 66. Japan Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 67. South Korea Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 68. China Taiwan Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 69. Southeast Asia Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 70. India Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 71. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Country (2019-2030)

Figure 76. Middle East, Africa and Latin America Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Country (2019-2030)

Figure 77. Brazil Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 78. Mexico Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 79. Turkey Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 80. Israel Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 81. GCC Countries Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (2019-2030) & (US$ Million)

Figure 82. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Value Chain

Figure 83. Sodium & Glucose Cotransporter 2 (SGLT 2) Inhibitors Production Process

Figure 84. Channels of Distribution

Figure 85. Distributors Profiles

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Sodium dependent Glucose Co transporter 2 SGLT2 Market Research Report 2024

Global Empagliflozin API Market Research Report 2024

Global SGLT 2 Inhibitors for Type 2 Diabetes Treatment Market Research Report 2025

Global SGLT2 Inhibitors Market Research Report 2025

Global SGLT2 Inhibitor Market Insights Forecast to 2030

Sotagliflozin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Canagliflozin Market Research Report 2024

Drugs Targeting SLC Transporters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Solute Transporter Carrier SLC Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Empagliflozin Tablets Market Research Report 2025

Global Oral Antidiabetic Agents Market Insights Forecast to 2030

Global Canagliflozin API Market Research Report 2024

Global Aldose Reductase Inhibitor Market Research Report 2024

Global Eliglustat Reagent Market Research Report 2024

Global Luseogliflozin Market Research Report 2024

Global Sitagliptin API Market Research Report 2025

Dapagliflozin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alogliptin Benzoate Tablet Market Research Report 2024

Global Miglitol API Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions